201 related articles for article (PubMed ID: 18723211)
1. Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy.
Froehner M; Koch R; Litz RJ; Oehlschlaeger S; Twelker L; Hakenberg OW; Wirth MP
Urology; 2008 Dec; 72(6):1252-7. PubMed ID: 18723211
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity is poor predictor of survival in patients undergoing radical prostatectomy after 70 years of age.
Froehner M; Koch R; Litz RJ; Hakenberg OW; Oehlschlaeger S; Wirth MP
Urology; 2006 Sep; 68(3):583-6. PubMed ID: 16979740
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomy.
Froehner M; Koch R; Litz RJ; Oehlschlaeger S; Hakenberg OW; Wirth MP
Eur Urol; 2005 Feb; 47(2):190-5; discussion 195. PubMed ID: 15661413
[TBL] [Abstract][Full Text] [Related]
4. Interaction between age and comorbidity as predictors of mortality after radical prostatectomy.
Froehner M; Koch R; Litz RJ; Hakenberg OW; Oehlschlaeger S; Wirth MP
J Urol; 2008 May; 179(5):1823-9; discussion 1829. PubMed ID: 18355873
[TBL] [Abstract][Full Text] [Related]
5. Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomy.
Froehner M; Koch R; Litz RJ; Haase M; Klenk U; Oehlschlaeger S; Baretton GB; Wirth MP
Scand J Urol Nephrol; 2005; 39(6):449-54. PubMed ID: 16303719
[TBL] [Abstract][Full Text] [Related]
6. Nomogram underestimates 10-year survival in healthy men selected for radical prostatectomy at age 70 years or older.
Froehner M; Koch R; Litz RJ; Wirth MP
Urology; 2009 Mar; 73(3):610-3; discussion 613-4. PubMed ID: 19167030
[TBL] [Abstract][Full Text] [Related]
7. A Mediterranean age-comorbidity prognostic index for survival in dialysis populations.
Fernandez Lucas M; Teruel JL; Zamora J; Lopez Mateos M; Rivera M; Ortuno J
J Nephrol; 2007; 20(6):696-702. PubMed ID: 18046672
[TBL] [Abstract][Full Text] [Related]
8. Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study.
Lund L; Borre M; Jacobsen J; Sørensen HT; Nørgaard M
Urology; 2008 Dec; 72(6):1258-62. PubMed ID: 18342917
[TBL] [Abstract][Full Text] [Related]
9. Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.
Abdollah F; Sun M; Schmitges J; Thuret R; Bianchi M; Shariat SF; Briganti A; Jeldres C; Perrotte P; Montorsi F; Karakiewicz PI
J Urol; 2012 Jul; 188(1):73-83. PubMed ID: 22578732
[TBL] [Abstract][Full Text] [Related]
10. 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.
Alibhai SM; Leach M; Tomlinson G; Krahn MD; Fleshner N; Holowaty E; Naglie G
J Natl Cancer Inst; 2005 Oct; 97(20):1525-32. PubMed ID: 16234566
[TBL] [Abstract][Full Text] [Related]
11. The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting.
Kastner C; Armitage J; Kimble A; Rawal J; Carter PG; Venn S
Prostate Cancer Prostatic Dis; 2006; 9(3):270-4. PubMed ID: 16770340
[TBL] [Abstract][Full Text] [Related]
12. Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy.
Boorjian SA; Karnes RJ; Rangel LJ; Bergstralh EJ; Blute ML
J Urol; 2008 Apr; 179(4):1354-60; discussion 1360-1. PubMed ID: 18289596
[TBL] [Abstract][Full Text] [Related]
13. Pathologic T2 stage subgroups and recurrence-free survival after radical prostatectomy.
DeCastro GJ; McCann T; Benson MC; McKiernan JM
Urology; 2008 Dec; 72(6):1214-8. PubMed ID: 18597825
[TBL] [Abstract][Full Text] [Related]
14. Which conditions contributing to the Charlson score predict survival after radical prostatectomy?
Froehner M; Koch R; Litz R; Oehlschlaeger S; Wirth MP
J Urol; 2004 Feb; 171(2 Pt 1):697-9. PubMed ID: 14713789
[TBL] [Abstract][Full Text] [Related]
15. Competing mortality contributes to excess mortality in patients with poor-risk lymph node-positive prostate cancer treated with radical prostatectomy.
Froehner M; Scholz A; Koch R; Hakenberg OW; Baretton GB; Wirth MP
Urol Int; 2012; 89(2):148-54. PubMed ID: 22813937
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic radical prostatectomy is feasible and effective in 'fit' senior men with localized prostate cancer.
Sanchez-Salas R; Prapotnich D; Rozet F; Mombet A; Cathala N; Barret E; Galiano M; Cathelineau X; Vallancien G
BJU Int; 2010 Nov; 106(10):1530-6. PubMed ID: 20230390
[TBL] [Abstract][Full Text] [Related]
17. Risk stratification of high-grade prostate cancer treated with antegrade radical prostatectomy with intended wide resection.
Yamamoto S; Kawakami S; Yonese J; Fujii Y; Tsukamoto T; Ohkubo Y; Komai Y; Ishikawa Y; Fukui I
Jpn J Clin Oncol; 2009 Jun; 39(6):387-93. PubMed ID: 19395463
[TBL] [Abstract][Full Text] [Related]
18. Changing comorbidity classification patterns at radical prostatectomy during a 10-year period.
Froehner M; Garbrecht B; Hakenberg OW; Koch R; Litz RJ; Oehlschlaeger S; Twelker L; Wirth MP
Urol Oncol; 2007; 25(1):26-31. PubMed ID: 17208135
[TBL] [Abstract][Full Text] [Related]
19. The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases.
Walz J; Montorsi F; Jeldres C; Suardi N; Shariat SF; Perrotte P; Arjane P; Graefen M; Pharand D; Karakiewicz PI
BJU Int; 2008 Apr; 101(7):826-32. PubMed ID: 18321316
[TBL] [Abstract][Full Text] [Related]
20. Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study.
Houterman S; Janssen-Heijnen ML; Hendrikx AJ; van den Berg HA; Coebergh JW
Crit Rev Oncol Hematol; 2006 Apr; 58(1):60-7. PubMed ID: 16213153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
